Learn more about CURE-CKD's work in the article published in the newest issue of ACP Internist.
It's bad enough that millions of Americans have diabetes and chronic kidney disease (CKD). Worse still is how many of them are unaware of their condition, according to experts who spoke at the American Diabetes Association's 2020 Scientific Sessions, held virtually in June.
“In the United States, diabetes is the leading cause of new cases of end-stage kidney disease, accounting for about 47% of new cases,” said Nilka Rios Burrows, MPH, an epidemiologist in the CDC's Division of Diabetes Translation and lead of the agency's CKD Initiative. “In the U.S., and also globally, the level of CKD awareness is less than 10% in the general population of CKD patients.” continued here
Keith Norris, MD
Dr. Keith C. Norris is an internationally recognized clinician scientist and health policy leader who has been instrumental in shaping national health policy and clinical practice guidelines for chronic kidney disease (CKD). After graduating Howard University College of Medicine, he completed his residency training and chief residency in internal medicine at Howard University and nephrology at the combined West Los Angeles Veterans Administration-UCLA program. In addition to being board certified in internal medicine and nephrology, he is an American Society of Hypertension, Specialist in Clinical Hypertension. In 2014, he received his doctorate in religious, spiritual and metaphysical philosophy.
His research interests focus on hypertension and CKD in disadvantaged populations. Other research areas include the role of Vitamin D and oxidative stress in health disparities, and enhancing community-academic partnerships. Dr. Norris was the founding Principal Investigator for the first national translational research network dedicated to reducing health disparities, the NIH-RCMI Translational Research Network. Presently, he directs the NIH Diversity Program Consortium Coordination and Evaluation Center at UCLA, the centerpiece of a new $230M NIH initiative to enhance diversity in the biomedical workforce.
Kathy Tuttle, MD
Katherine R. Tuttle, MD, FASN, FACP, FNKF, is Executive Director for Research at Providence Health Care, Co-Principal Investigator of the Institute of Translational Health Sciences and Professor of Medicine at the University of Washington. Dr. Tuttle earned her medical degree and completed her residency in Internal Medicine at Northwestern University School of Medicine in Chicago, Illinois. She was a fellow in Metabolism and Endocrinology at Washington University in St. Louis, Missouri. Her Nephrology fellowship training was performed at University of Texas Health Science Center in San Antonio, Texas.
Dr. Tuttle’s major research interests are in clinical and translational science for diabetes and chronic kidney disease. She has published over 200 original research contributions and served two terms as Associate Editor for the Clinical Journal of the American Society of Nephrology and the American Journal of Kidney Disease. Dr. Tuttle has received many honors and awards including the Medal of Excellence from the American Association of Kidney Patients, Garbed Eknoyan Award from the National Kidney Foundation, the YWCA Woman of Achievement Award in Science, and two Outstanding Clinical Faculty Awards at the University of Washington. Dr. Tuttle served on the Board of Directors for the Kidney Health Initiative and has chaired numerous kidney and diabetes related working groups and committees for organizations including the NIDDK/NIH, the National Kidney Foundation, the American Society of Nephrology, the International Society of Nephrology, and the American Diabetes Association.
